Serina Therapeutics (SER) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by Co-Executive Chairman Simba Gill, with thanks extended to attendees and introduction of the CEO and Corporate Secretary, Steve Ledger.

• Agenda included eight proposals: election of directors, share increase, incentive plan amendment, conversion, private placement, say-on-pay, say-on-pay frequency, and auditor ratification.

• Meeting conducted in accordance with amended bylaws and rules of conduct, with procedures for voting and question submission outlined.

Board and executive committee updates

• Three board nominees presented: Gregory H. Bailey, Richard Marshall, and Jay Venkatesan, with no additional nominations received.

Shareholder proposals

• Proposals included share increase, 2024 Incentive Plan Amendment, conversion, private placement, say-on-pay, say-on-pay frequency, and auditor ratification.

• Board recommended approval for all proposals, including a three-year frequency for say-on-pay.